DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

Celgene Announces Will Offer Findings from Long-Term Post-Hoc Analysis of Pooled Data from PALACE Ph

Celgene Announces Will Offer Findings from Long-Term Post-Hoc Analysis of Pooled Data from PALACE Phase III Trial of Otezla at EULAR

Celgene: Philip Fisher's Kind Of Company

My Top 3 Pharma Stock Picks

Scared Of A Correction? Should You (Or Shouldn't You) Be?

Stocks To Watch in Orphan Drugs

Acceleron Pharma, bluebird bio, and Sarepta Therapeutics are three rare disease specialists with upcoming catalysts that could propel their shares higher.

Benzinga's M&A Chatter for Monday June 8, 2015

Benzinga's M&A Chatter for Monday June 8, 2015

Jim Cramer Explains What Markets Will Do When the Fed Raises Rates

3 Drugs Stocks Pushing Industry Growth

Sorrento Therapeutics And L.A.'s Richest Man Ally, Target Celgene's Blockbuster Abraxane

Cancer Drugs: 2 Stocks to Watch

AstraZeneca and Agenus Inc. are paving the way for a new generation of breakthrough cancer drugs that boost the immune system's ability to detect and eradicate malignancies. Here's what investors need to know about these two biopharmas going forward.